missing translation for 'onlineSavingsMsg'
Learn More
  1. Home
  2. Products
  3. Antibodies
  4. Primary Antibodies
  5. All Primary Antibodies
  6. LMO2 Rabbit anti-Human, Clone: LMO2/3147R, Novus Biologicals™
  7. 18352573

LMO2 Rabbit anti-Human, Clone: LMO2/3147R, Novus Biologicals™

Rabbit Monoclonal Antibody

Brand:  Novus Biologicals NBP3-07201-20UG

 View more versions of this product

Product Code. 18352573

  • £245.00 / 20µg

Please to purchase this item. Need a web account? Register with us today!

This item is not returnable. View return policy

Description

Description

LMO2 Monoclonal specifically detects LMO2 in Human samples. It is validated for Flow Cytometry, Immunocytochemistry/Immunofluorescence.
TRUSTED_SUSTAINABILITY
Specifications

Specifications

LMO2
Monoclonal
0.2 mg/ml
Flow Cytometry 1-2 ug/million cells, Immunocytochemistry/Immunofluorescence 1-2 ug/ml
Cysteine-rich protein TTG-2, LIM domain only 2 (rhombotin-like 1), LIM domain only protein 2, LMO-2, RBTN2rhombotin-2, RBTNL1rhombotin-like 1, RHOM2T-cell translocation protein 2, T-cell translocation gene 2, TTG2rhombotin 2
Recombinant fragment (around aa 23-140) human LMO2 protein (exact sequence is proprietary)
20 μg
Angiogenesis, Cancer
4005
Store at 4°C.
IgG
Flow Cytometry, Immunofluorescence
LMO2/3147R
Unconjugated
10 mM PBS with 0.05% BSA
Rabbit
Protein A or G purified
RUO
Primary
Human
Purified
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

Certificates
Promotions

Promotions

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Thank You! Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.